You are here

Weill Cornell Medical College and NewYork-Presbyterian Hospital License Technology to Lumendi, Ltd.

MINT has teamed up with entrepreneurs and investors to establish Lumendi, a new start-up company dedicated to producing next-generation endoscopic tools that make complex gastrointestinal surgeries safer and less expensive while also improving patient outcomes.

The agreement between Weill Cornell and Lumendi will advance the development of the Endolumenal Surgical Platform (ESP), a new disposable device which fits over a standard endoscope like a sleeve and provides increased stability, control and visualization within the intestine. The ESP is designed to transform the way gastrointestinal surgeries are performed by enabling clinicians to perform complex procedures endolumenally — from entirely within the intestine — resulting in less-invasive surgeries, quicker patient recovery and reduced healthcare costs.

In addition to the development of ESP, the MINT team and Lumendi plan to develop a series of new products that are designed to enhance the ESP.

To learn more about this exciting development and read the full press release please visit the Weill Cornell Newsroom 

To learn more about Lumendi please visit